• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Healthcare·2393.HK
Share

Yestar Healthcare Holdings Company Limited Stocks

HK$ 0.07Last Updated 23.06.2026

Issuer Rating

3/7
Performance

Favourable

Risk

High

Recommendation

Sell

Market Cap

HK$ 21.42M

HK$ 0.07
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Yestar Healthcare Holdings Company Limited functions as an investment holding entity primarily dedicated to the creation, distribution, and sale of medical imaging goods across mainland China. The company's operations are divided into two principal segments: Imaging Printing Products and Medical Products and Equipment. The Imaging Printing Products division manufactures and supplies items such as Fujifilm color photographic paper, industrial non-destructive testing (NDT) X-ray films, and PWB films. It also trades in various types of imaging equipment. These offerings are employed in both professional and minilab environments, as well as for a range of industrial imaging applications. The NDT X-ray films are specifically marketed under the 'Yes!Star' brand. Conversely, the Medical Products and Equipment segment produces and delivers medical dry and wet films, in addition to dental films. This segment also commercially provides medical equipment and diagnostic reagents, and is engaged in the distribution of in vitro diagnostic products. Furthermore, Yestar Healthcare is involved in biotechnology development initiatives, oversees supply chain management, and offers freight transportation services. Established in 1971, the company operated under the name Yestar International Holdings Company Limited until it adopted its current designation in January 2017. Its corporate headquarters are situated in Shanghai, People's Republic of China.

Company Valuation

Greatly undervalued
7/7

From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks. Specifically, the stock is undervalued on EV/EBITDA, und

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

24.06.2026 20:36

Fast-food chain Wendy’s soars 40% on meme-stock hype

24.06.2026 19:11

Rheinmetall Is Close to Its Worst Day Since 1989: Why Have European Defense Stocks Plummeted?

24.06.2026 18:40

A Wake-Up Call: Why a Value Investing Guru Is Concerned About the Wave of Mega-IPOs

24.06.2026 18:15

Gold fell below $4,000—for the first time since November. Is the precious metal's rally over?

24.06.2026 17:39

The next two years will show which AI companies investors should have avoided — Jim Chanos

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026